BioNeutra International, Ltd.
BIMO · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $10 | $7 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $10 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | 79.3% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -156.8% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -177.4% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | -33.3% | 25% | -300% | – |
| Operating Cash Flow | -$0 | – | $0 | -$0 |
| Capital Expenditures | $0 | – | $0 | $0 |
| Free Cash Flow | -$0 | – | $0 | -$0 |